| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $3,249 | 1 | 50 |
Sells | $2,209,482 | 1 | 50 |
| Sharma Mani | See Remarks | 1 | $3,249 | 1 | $2.21M | $-2.21M |
AstraZeneca PLC operates as a global biopharmaceutical leader, dedicated to the entire process of bringing prescription medicines to market, from their initial discovery and development through manufacturing and commercialization. The company's extensive portfolio of treatments, including prominent examples like Tagrisso, Farxiga, and Symbicort, addresses critical areas such as cardiovascular, renal, metabolic, and oncological conditions. Furthermore, it provides essential solutions for COVID-19 and various rare diseases, with products like …
Over the last 12 months, insiders at AstraZeneca PLC have bought $3,249 and sold $2.21M worth of AstraZeneca PLC stock.
On average, over the past 5 years, insiders at AstraZeneca PLC have bought $3,249 and sold $2.21M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Sharma Mani (See Remarks) — $3,249.
The last purchase of 20 shares for transaction amount of $3,249 was made by Sharma Mani (See Remarks) on 2026‑08‑08.
| 2026-08-08 | Sharma Mani | See Remarks | 20.23 <0.0001% | $160.57 | $3,249 | +1.16% | ||
| 2026-05-20 | Sale | Sharma Mani | See Remarks | 11,893 0.0008% | $185.78 | $2.21M | -9.74% |
| Increased Positions | 781 | +59.66% | 26M | +10.38% |
| Decreased Positions | 541 | -41.33% | 26M | -10.61% |
| New Positions | 245 | New | 4M | New |
| Sold Out Positions | 123 | Sold Out | 2M | Sold Out |
| Total Postitions | 1,549 | +18.33% | 247M | -0.23% |